Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats.
about
Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J miceInfluence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses.Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity.Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cellsIn vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell typesLong terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.Ikaros, a lymphoid-cell-specific transcription factor, contributes to the leukemogenic phenotype of a mink cell focus-inducing murine leukemia virusIdentification of 3' alpha-hs4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation.Duplication of U3 sequences in the long terminal repeat of mink cell focus-inducing viruses generates redundancies of transcription factor binding sites important for the induction of thymomasFunction of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeatReceptor-mediated leukaemogenesis: hypothesis revisitedThe feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicityInducible and cell type-specific expression of VL30 U3 subgroups correlate with their enhancer design.Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activityNuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell linesIdentification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific elementDistinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney virusesDifferences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.Relative importance of elements within the SL3-3 virus enhancer for T-cell specificitySequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia virusesIdentification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences.Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia virusesSelective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.Identification of LTR-specific small non-coding RNA in FeLV infected cells.Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.Alteration from T- to B-cell tropism reduces thymic atrophy and cytocidal effects in thymocytes but not neurovirulence induced by ts1, a mutant of Moloney murine leukemia virus TB.Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sitesInsertional oncogenesis by non-acute retroviruses: implications for gene therapy.Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.Involvement of nuclear factor I-binding sites in control of Akv virus gene expression.Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
P2860
Q30452113-7ADB685C-CDD0-4CE2-8ABA-1E9AE5204CD3Q30452207-16FA1481-D18F-49FF-ABCE-1FFBE9E7FCEDQ33639086-4D65E316-CFF6-434F-A2A4-437961EB41B5Q33648866-B1E5DC45-E090-4815-9AD1-6373DBFC8E5DQ33682150-11503C3A-DCCE-4481-8710-94C1A3A1D95FQ33785327-1D088B75-8FA0-4F63-BE30-6B1C85FFF390Q33811928-EF6DDBB4-6082-416F-B18D-F385D83A1DE1Q33814106-7174DBA6-201E-407D-B8F2-AA4A73F3D995Q34069593-1EC5EE7B-79A4-49CF-8327-23782DC3E42EQ34327052-9A0E2394-70BA-4EFF-AF60-8394E3378942Q34742867-5586E7F0-D65D-48A3-90C7-C72F74678D87Q34757976-CF11AC84-BD9C-439A-9521-6308C255A4E7Q35839448-ABC455FF-2C64-431B-9DFD-3270A7121498Q36230303-0511815A-7E55-48A7-AC11-33136A5B4642Q36290235-50A5D6CC-B442-48A6-B5B3-C52A7FAE3704Q36549315-0B9F8518-1530-456C-9F1E-A08798041E2CQ36619591-093AF15E-C533-4BDC-9501-01A04D1293E2Q36654359-5B6272F2-37BA-4A43-953D-1A5B74364FCFQ36684305-480882EF-4D0C-4C78-927B-859044AB1C9FQ36779962-4BFBF479-241D-4103-B3F1-83803FEA2D6DQ36780275-7FBE82AB-6F00-4BF4-8EED-FD1A794F5976Q36781432-11F6A922-6E09-4888-A65D-A8CE386E57D5Q36798128-C4094C0B-6148-4697-A39C-113F95642612Q36804010-1C539E1A-0F0C-4657-A46B-3C034662F46FQ36805717-9BA08A9F-2301-4422-8431-9DC7F620F359Q36820658-E7367B27-74F6-44DE-82E9-59F8B8D50DBEQ36828502-B9DD8A1E-CA28-489A-9D7C-26F534CF1D4DQ36828988-38043717-2D13-4A58-A689-279143DED6EFQ36830983-014C773D-43AE-456C-96E2-F0CD324A37A9Q36831856-06E9EF56-2FD7-492F-89C2-3396E74BD3D5Q36846338-7F685E84-BD59-4278-9C35-A88167130C58Q37176304-9AC08B2F-C0F8-4AE4-8F50-5FB57B83D78EQ37256742-9F5B2FDC-633C-4101-991B-97EDBE2BA77DQ37604192-4F8F19A1-55FE-45FB-A262-3D6FC85A3605Q37747920-546B94A6-E279-454D-A1EA-A6C3D70A64CBQ37945223-282C5E4C-6572-4345-97F7-EB0E520D7C66Q38293060-4EDC8429-B544-474E-8035-0FE246ADF92CQ38296037-94ED41AA-4B0C-4677-BCB7-70CEF938F911Q38339444-420DA2FB-61B1-4769-9312-2121D0118754Q39403641-9B541506-E5E6-4184-9A76-F540A0985762
P2860
Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Correlation of leukemogenic po ...... e viral long terminal repeats.
@en
type
label
Correlation of leukemogenic po ...... e viral long terminal repeats.
@en
prefLabel
Correlation of leukemogenic po ...... e viral long terminal repeats.
@en
P2093
P2860
P1433
P1476
Correlation of leukemogenic po ...... he viral long terminal repeats
@en
P2093
P2860
P304
P407
P577
1987-04-01T00:00:00Z